Chandrasekher Y A, Hutchison J S, Zelinski-Wooten M B, Hess D L, Wolf D P, Stouffer R L
Division of Reproductive Sciences, Oregon Regional Primate Research Center, Beaverton 97006.
J Clin Endocrinol Metab. 1994 Jul;79(1):298-306. doi: 10.1210/jcem.79.1.8027245.
The amplitude and duration of the midcycle LH surge required for periovulatory changes in the primate follicle are incompletely defined. We reported that short (4- to 14-h) LH surges were insufficient to induce periovulatory events after multiple follicular development in macaques. In contrast, an 18- to 24-h LH surge induced oocyte maturation plus granulosa cell luteinization, but did not support corpus luteum function. In this study, the periovulatory changes following LH surges of 48 h elicited using pituitary (pit) or recombinant (r) human (h) LH were compared to those after 24-h LH surge durations or after urinary hCG (u-hCG) treatment. Beginning at menses, rhesus monkeys were treated with human gonadotropins for 9 days to stimulate follicular growth. On day 10, animals (n = 3-5/group) received 1) a single injection of u-hCG [79 +/- 3 micrograms RP-1 equivalents (equiv), im], 2) two injections of pit-hLH (91 +/- 4 micrograms RP-1 equiv, im), 3) one injection of r-hLH (21 +/- 1 micrograms RP-1 equiv, im), or 4) two injections of r-hLH (21 +/- 1 micrograms RP-1 equiv). Oocytes and granulosa cells were obtained via follicle aspiration 27 h after the initial LH or hCG injection. In all groups, serum estradiol rose to similar peak levels by day 10. Circulating LH-like bioactivity was elevated for more than 48 h after u-hCG. Peak serum LH bioactivities were proportional to the administered LH doses, as determined in the in vitro bioassay. Two injections of either r-hLH or pit-hLH elicited surge levels (> 100 ng/mL) of bioactive LH for 36-48 h, whereas one injection sustained surge levels for only 18-24 h. The proportions of oocytes resuming meiosis (68-76%) were similar in all groups. Immunocytochemical staining for progesterone receptor and in vitro progesterone production by granulosa cells in all LH-treated groups were comparable to those of cells form the hCG-treated group. Peak levels of progesterone in the luteal phase were comparable in monkeys treated with two doses of pit-hLH and r-hLH (18.5 +/- 10.4 vs. 8.1 +/- 1.5 ng/mL) and approached that in u-hCG treated monkeys (39.5 +/- 18.0 ng/mL). However, progesterone levels in animals treated once with r-hLH (3.4 +/- 1.5 ng/mL) were less (P < 0.05) than those in u-hCG-treated monkeys.(ABSTRACT TRUNCATED AT 400 WORDS)
灵长类动物卵泡排卵中期促黄体生成素(LH)峰的幅度和持续时间与排卵相关变化的关系尚未完全明确。我们曾报道,短时间(4至14小时)的LH峰不足以在猕猴多个卵泡发育后诱导排卵相关事件。相比之下,18至24小时的LH峰可诱导卵母细胞成熟及颗粒细胞黄体化,但不支持黄体功能。在本研究中,将使用垂体(pit)或重组(r)人(h)LH引发的48小时LH峰后的排卵相关变化,与24小时LH峰持续时间后或尿促性腺激素(u-hCG)治疗后的变化进行比较。从月经开始,恒河猴接受人促性腺激素治疗9天以刺激卵泡生长。在第10天,动物(每组n = 3 - 5只)接受:1)单次注射u-hCG [79 ± 3微克RP-1当量(equiv),肌肉注射],2)两次注射pit-hLH(91 ± 4微克RP-1 equiv,肌肉注射),3)单次注射r-hLH(21 ± 1微克RP-1 equiv,肌肉注射),或4)两次注射r-hLH(21 ± 1微克RP-1 equiv)。在首次LH或hCG注射后27小时,通过卵泡抽吸获取卵母细胞和颗粒细胞。在所有组中,到第10天血清雌二醇升至相似的峰值水平。u-hCG后循环中的LH样生物活性升高超过48小时。如体外生物测定所确定的,血清LH生物活性峰值与所给予的LH剂量成比例。两次注射r-hLH或pit-hLH可引发生物活性LH的峰水平(> 100 ng/mL)达36至48小时,而单次注射仅维持峰水平18至24小时。所有组中恢复减数分裂的卵母细胞比例(68 - 76%)相似。所有LH治疗组中颗粒细胞的孕酮受体免疫细胞化学染色及体外孕酮产生与hCG治疗组细胞相当。用两剂pit-hLH和r-hLH治疗的猕猴黄体期孕酮峰值水平相当(18.5 ± 10.4对8.1 ± 1.5 ng/mL),并接近u-hCG治疗猕猴的水平(39.5 ± 18.0 ng/mL)。然而,单次注射r-hLH治疗的动物孕酮水平(3.4 ± 1.5 ng/mL)低于(P < 0.05)u-hCG治疗的猕猴。(摘要截断于400字)